Treatment for Hypoxia

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Hypoxia
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test how well a new device prototype works in measuring oxygen and movement.

Eligible Conditions
  • Hypoxia

Treatment Effectiveness

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 15-20 minutes depending on the patients questions.

15 hours
Comparing Dove device against FDA approved SpO2 sensor
15-20 minutes depending on the patients questions.
Questionnaire about comfort of device

Trial Safety

Trial Design

0 Treatment Group

40 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 15-20 minutes depending on the patients questions.

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
1,844 Previous Clinical Trials
41,138,048 Total Patients Enrolled
3 Trials studying Hypoxia
155 Patients Enrolled for Hypoxia

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: